Dr. Gehchan brings 20 years of U.S. and international experience across multiple therapeutic areas, including immunology, as both an accomplished pharmaceutical executive and a physician to this newly ...
Pfizer (PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations ...
RFK Jr., Trump's health secretary pick, slammed for 'embracing conspiracy theories' during confirmation hearing: Live updates - Robert F Kennedy Jr is answering questions from Senate Finance Committee ...
Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...
NRx Pharmaceuticals (NRXP) announced that it has entered into a binding agreement for a registered direct offering of its common stock with expected gross proceeds of $3.5M with certain ...
PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...
In trading on Thursday, shares of NewAmsterdam Pharma Company N V (Symbol: NAMS) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $19.60 per share.
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Getting addicted, no pun intended, to an animated conspiracy thriller from Adult Swim ...
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports.
Failed honey biotech firm TRG Natural Pharmaceuticals owes creditors more than $1.2 million, according to the liquidators’ first report. The Tauranga-based company was placed into liquidation at the ...
Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results